Friess Associates’s Zoetis ZTS Stock Holding History

Friess Associates’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-116,779	Closed	-$19.3M	–	132
2020 Q3	$19.3M	Hold	116,779	–	–	1.67%	29
2020 Q2	$16M	Sell	116,779 -10,698	-8%	-$1.4M	1.49%	25
2020 Q1	$15M	Buy	+127,477	New	+$16.8M	1.5%	26
2018 Q3	–	Sell	-310,643	Closed	-$26.5M	–	139
2018 Q2	$26.5M	Sell	310,643 -130	-0%	-$11K	2.09%	4
2018 Q1	$26M	Sell	310,773 -117	-0%	-$9.22K	2.12%	3
2017 Q4	$22.4M	Buy	310,890 +700	+0.2%	+$48.1K	1.85%	7
2017 Q3	$19.8M	Buy	310,190 +5,190	+2%	+$325K	1.73%	13
2017 Q2	$19M	Buy	305,000 +45,000	+17%	+$2.66M	1.73%	6
2017 Q1	$13.9M	Buy	+260,000	New	+$14M	1.31%	40
2016 Q3	–	Sell	-336,000	Closed	-$15.9M	–	162
2016 Q2	$15.9M	Buy	+336,000	New	+$15.9M	1.63%	27

Other funds holding ZTS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Friess Associates's ZTS Position: Q4 2020 in Review

Friess Associates sold out of Zoetis (ZTS) in Q4 2020, closing a stake of 116,779 shares — an estimated $19.3M sold.

Friess Associates first reported a position in ZTS in Q2 2016 and held it in 10 quarters. The position peaked at $26.5M in Q2 2018. 1,410 funds tracked by Wall St. Rank hold ZTS as of Q4 2020.

Friess Associates reported no remaining Zoetis position as of Q4 2020 after selling out during the quarter.
Friess Associates sold 116,779 Zoetis shares in Q4 2020, an estimated $19.3M.
Friess Associates first reported a position in Zoetis in Q2 2016 and held it in 10 quarters.
Friess Associates's Zoetis position peaked at $26.5M in Q2 2018.
1,410 funds tracked by Wall St. Rank held Zoetis as of Q4 2020.

Based on Friess Associates's 13F filing for Q4 2020, filed 12 Feb 2021.